Edition:
United States

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

0.80USD
11:01am EDT
Change (% chg)

$-0.04 (-4.20%)
Prev Close
$0.84
Open
$0.83
Day's High
$0.83
Day's Low
$0.80
Volume
66,534
Avg. Vol
169,361
52-wk High
$3.78
52-wk Low
$0.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.198
Mar '18 0.00 -0.288
FY 2017 Dec '17 0.25 -0.237
Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.97
Earnings (per share)
Quarter Ending Sep-18 3 -0.13 -0.09 -0.22 -0.36
Quarter Ending Dec-18 3 -0.14 -0.09 -0.23 -0.37
Year Ending Dec-18 3 -0.68 -0.54 -0.95 -1.18
Year Ending Dec-19 3 -0.56 -0.34 -0.95 -1.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.45 32.71
P/E High - Last 5 Yrs. -- 279.26 47.27
P/E Low - Last 5 Yrs. -- 98.01 24.80
Beta -- 0.61 0.87
Price to Sales (TTM) 117.93 110.80 6.42
Price to Book (MRQ) 1.29 12.48 3.91
Price to Tangible Book (MRQ) 1.29 18.85 5.97
Price to Cash Flow (TTM) -- 62.31 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 179.03 8.45
Sales (TTM) vs TTM 1 Yr. Ago -- 93.99 6.71
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago 38.13 283.55 25.51
EPS (TTM) vs TTM 1 Yr. Ago 40.75 -- --
EPS - 5 Yr. Growth Rate -- 23.64 7.60
Capital Spending - 5 Yr. Growth Rate -30.83 38.63 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.20
Current Ratio (MRQ) 10.22 5.47 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.21
Total Debt to Equity (MRQ) 1.81 18.60 14.02
Interest Coverage (TTM) -69.07 -198.17 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.73
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -5,289.00 -- --
EBITD - 5 Yr. Avg -26,528.40 -176.77 15.89
Operating Margin (TTM) -5,337.80 -608.74 3.72
Operating Margin - 5 Yr. Avg. -26,822.20 -190.37 11.01
Pre-Tax Margin (TTM) -5,329.00 -605.96 4.04
Pre-Tax Margin - 5 Yr. Avg. -27,211.20 -192.95 11.19
Net Profit Margin (TTM) -5,329.00 -600.63 0.77
Net Profit Margin - 5 Yr. Avg. -27,211.20 -190.59 7.53
Effective Tax Rate (TTM) -- 11.58 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.15 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,333,198 715,149,750
Net Income/Employee (TTM) -- -5,689,194 82,590,366
Receivable Turnover (TTM) -- 4.22 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.01 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -65.26 0.77 9.73
Return on Assets - 5 Yr. Avg. -83.24 2.50 10.90
Return on Investment (TTM) -77.71 1.54 12.72
Return on Investment - 5 Yr. Avg. -99.87 1.99 14.02
Return on Equity (TTM) -79.11 0.30 14.84
Return on Equity - 5 Yr. Avg. -- -2.37 15.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.24%
# of Holders: 37
Total Shares Held: 37,108,145
3 Mo. Net Change: 26,497,601
# New Positions: 13
# Closed Positions: 7
# Increased Positions: 21
# Reduced Positions: 13
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.